7,041 reports of this reaction
1.8% of all CELECOXIB reports
#11 most reported adverse reaction
MYOCARDIAL INFARCTION is the #11 most commonly reported adverse reaction for CELECOXIB, manufactured by Viatris Specialty LLC. There are 7,041 FDA adverse event reports linking CELECOXIB to MYOCARDIAL INFARCTION. This represents approximately 1.8% of all 402,054 adverse event reports for this drug.
Patients taking CELECOXIB who experience myocardial infarction should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
MYOCARDIAL INFARCTION is a less commonly reported adverse event for CELECOXIB, but still significant enough to appear in the safety profile.
In addition to myocardial infarction, the following adverse reactions have been reported for CELECOXIB:
The following drugs have also been linked to myocardial infarction in FDA adverse event reports:
MYOCARDIAL INFARCTION has been reported as an adverse event in 7,041 FDA reports for CELECOXIB. This does not prove causation, but indicates an association observed in post-market surveillance data.
MYOCARDIAL INFARCTION accounts for approximately 1.8% of all adverse event reports for CELECOXIB, making it a notable side effect.
If you experience myocardial infarction while taking CELECOXIB, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.